# Relative Bioavailability and Food Effect Study

> **NCT01489488** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 32 (actual)

## Conditions studied

- Pharmacology, Clinical

## Interventions

- **DRUG:** Riociguat (BAY63-2521)
- **DRUG:** Riociguat (BAY63-2521)
- **DRUG:** Riociguat (BAY63-2521)
- **DRUG:** Riociguat (BAY63-2521)
- **DRUG:** Riociguat (BAY63-2521)

## Key facts

- **NCT ID:** NCT01489488
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-04
- **Final completion:** 2012-05
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2015-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01489488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01489488, "Relative Bioavailability and Food Effect Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01489488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*